Cover Image

Cyclin‐dependent kinase 12‐mediated super‐enhancers as promising targets in cancer therapy

Saved in:

Bibliographic Details
Main Authors:	Fuda Xie (Author), Bonan Chen (Author), Xiaoli Liu (Author), Jun Yu (Author), Ka Fai To (Author), Wei Kang (Author)
Format:	Book
Published:	Wiley, 2022-12-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeting Protein-Protein Interactions to Inhibit Cyclin-Dependent Kinases
by: Mark Klein
Published: (2023)

The CRM1‐mediated nuclear export effectuates the role conversion of tumour suppressor gene BATF2 in colorectal cancer
by: Peiyao Yu, et al.
Published: (2023)

CELL CYCLE REGULATOR: CYCLIN DEPENDENT KINASE 10 AS POTENTIAL TARGET IN CANCER
by: Muhammad Fazal Hussain Qureshi, et al.
Published: (2019)

Targeting the oncogenic LARP1/DKK4/β‐catenin axis in hepatoblastoma
by: Fuda Xie, et al.
Published: (2023)

Clinicopathological value of the upregulation of cyclin-dependent kinases regulatory subunit 2 in osteosarcoma
by: Chaohua Mo, et al.
Published: (2022)

Mint3‐targeted therapy: A novel therapeutic strategy for urothelial carcinoma
by: Fuda Xie, et al.
Published: (2023)

PRACTICAL ASPECTS OF ADMINISTERING CYCLIN-DEPENDENT KINASES INHIBITORS: EFFICACY AND TOLERABILITY
by: E. V. Artamonova
Published: (2018)

Small molecule inhibitors of cyclin-dependent kinase 9 for cancer therapy
by: Aisha Alsfouk
Published: (2021)

Cyclin-Dependent Kinase Inhibitors and Their Therapeutic Potential in Colorectal Cancer Treatment
by: Oana-Maria Thoma, et al.
Published: (2021)

Cyclin-dependent kinases-based synthetic lethality: Evidence, concept, and strategy
by: Kailin Li, et al.
Published: (2021)

Inflammation Resolution and the Induction of Granulocyte Apoptosis by Cyclin-Dependent Kinase Inhibitor Drugs
by: Jennifer A. Cartwright, et al.
Published: (2019)

Cyclin-Dependent Kinase and Antioxidant Gene Expression in Cancers with Poor Therapeutic Response
by: George S. Scaria, et al.
Published: (2020)

The Resistance of Cancer Cells to Palbociclib, a Cyclin-Dependent Kinase 4/6 Inhibitor, is Mediated by the ABCB1 Transporter
by: Han Fu, et al.
Published: (2022)

Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer
by: Md Sazzad Hassan, et al.
Published: (2021)

The kinome, cyclins and cyclin-dependent kinases of pituitary adenomas, a look into the gene expression profile among tumors from different lineages
by: Keiko Taniguchi-Ponciano, et al.
Published: (2022)

Nestin Improves Preeclampsia-Like Symptoms by Inhibiting Activity of Cyclin-Dependent Kinase 5
by: Xu Yang, et al.
Published: (2018)

The crosstalk between the RNA demethylase, non‐coding RNAs, and transcription factors in gastric cancer: An ALKBH5 perspective
by: Fuda Xie, et al.
Published: (2023)

CYCLIN-DEPENDENT KINASE INHIBITOR, PALBOCICLIB - A NEW DRUG FOR THE TREATMENT OF METASTATIC BREAST CANCER
by: E. N. Imyanitov, et al.
Published: (2017)

Hormone therapy for premenopausal women with metastatic breast cancer: combinations with cyclin-dependent kinase inhibitors
by: E. V. Artamonova, et al.
Published: (2019)

Cyclin-dependent kinase 9 (CDK9) predicts recurrence in Middle Eastern epithelial ovarian cancer
by: Sandeep Kumar Parvathareddy, et al.
Published: (2021)

Involvement of Phosphatase and Tensin Homolog in Cyclin-Dependent Kinase 4/6 Inhibitor-Induced Blockade of Glioblastoma
by: Songlin Liu, et al.
Published: (2019)

Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral Strategies
by: Debora Obergfäll, et al.
Published: (2024)

Stress Activated MAP Kinases and Cyclin-Dependent Kinase 5 Mediate Nuclear Translocation of Nrf2 via Hsp90α-Pin1-Dynein Motor Transport Machinery
by: Tetsuro Ishii, et al.
Published: (2023)

Expression Profile and Molecular Basis of Cyclin-Dependent Kinases Regulatory Subunit 2 in Endometrial Carcinoma Detected by Diversified Methods
by: Li Gao, et al.
Published: (2022)

High throughput screens yield small molecule inhibitors of Leishmania CRK3:CYC6 cyclin-dependent kinase.
by: Roderick G Walker, et al.
Published: (2011)

Cyclin dependant kinase inhibitor 2A/B and IKZF-1 gene deletions in childhood acute lymphoblastic leukemia
by: M. Agarwal, et al.
Published: (2016)

Cyclin-Dependent Kinase 1 Inhibition Potentiates the Proliferation of Tonsil-Derived Mesenchymal Stem Cells by Delaying Cellular Senescence
by: Da Hyeon Choi, et al.
Published: (2022)

Arcyriaflavin a, a cyclin D1-cyclin-dependent kinase4 inhibitor, induces apoptosis and inhibits proliferation of human endometriotic stromal cells: a potential therapeutic agent in endometriosis
by: Tomoko Hirakawa, et al.
Published: (2017)

Identification of abemaciclib derivatives targeting cyclin-dependent kinase 4 and 6 using molecular dynamics, binding free energy calculation, synthesis, and pharmacological evaluation
by: Yanting Zhou, et al.
Published: (2023)

Clinical use of Abemaciclib a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with breast cancer - literature review
by: Katarzyna Maria Krukar, et al.
Published: (2024)

Strategies for Early Prediction and Timely Recognition of Drug-Induced Liver Injury: The Case of Cyclin-Dependent Kinase 4/6 Inhibitors
by: Emanuel Raschi, et al.
Published: (2019)

SNS-032 attenuates liver fibrosis by anti-active hepatic stellate cells via inhibition of cyclin dependent kinase 9
by: Xiao-Li He, et al.
Published: (2022)

Vitiligo-like lesions induced by cyclin-dependent kinase 4/6 inhibitor Palbociclib: a case report and literature review
by: Shan Gao, et al.
Published: (2023)

Discovery of 3,6-disubstituted pyridazines as a novel class of anticancer agents targeting cyclin-dependent kinase 2: synthesis, biological evaluation and in silico insights
by: Ahmed Sabt, et al.
Published: (2020)

A phase 1 study of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor in Chinese patients with advanced breast cancer
by: Pin Zhang, et al.
Published: (2021)

Locoregional Radiotherapy in Patients with Advanced Breast Cancer Treated with Cyclin-Dependent Kinase 4/6 Inhibitors Based on Real-World Data
by: Marcin Kubeczko, et al.
Published: (2024)

Hsa_circ_0056558 regulates cyclin-dependent kinase 6 by sponging microRNA-1290 to suppress the proliferation and differentiation in ankylosing spondylitis
by: Xia Li, et al.
Published: (2021)

The Effects of Anlotinib Combined with Chemotherapy following Progression on Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive Metastatic Breast Cancer
by: Ting Xu, et al.
Published: (2024)

Alkylaminophenol Induces G1/S Phase Cell Cycle Arrest in Glioblastoma Cells Through p53 and Cyclin-Dependent Kinase Signaling Pathway
by: Phuong Doan, et al.
Published: (2019)

Retraction Note: Neuroprotective effect of Buyang Huanwu Decoction on spinal ischemia-reperfusion injury in rats is linked with inhibition of cyclin-dependent kinase 5
by: Lei Wang, et al.
Published: (2022)